 |
|
АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология |
Приложение 8. 239 9 страница1239. Nelson Т.Е., Flewellen E.H. (1983). The malignant hyperthermia syndrome, N. Engl. Med., 309, 416-418. 1240. Neufeld E. F. (1974). The biochemical basis for Литература mucopolysaccharidoses and mucolipidoses, Prog. Med. Genet., 10, 81-101. 1241. Nettfeld E. F., Barton Я W. (1972). Genetic disorders of mucopolysaccharide metabolism. In: Gaull G. E. (ed.), Biology of brain dysfunction, pp. 1-30, Plenum, New York. 1242. Neufeld E. F., McKusickV.A. (1983). Disorders of lysosomal enzyme synthesis and localization: I-cell disease and Pseudo-Hurler polydystrophy. In: Stanbury J. B. et al. (eds.), The metabolic basis of inherited disease, 5th ed., McGraw-Hill Book Co, New York, etc., pp. 778-787. 1243. NewS.I., Levine L.S. (1973). Congenital adrenal hypoplasia, Adv. Hum. Genet., 4, 251-326. 1244. Ng W.G., Rae T.F., DonnellG.N. (1983). Disorders of carbohydrate metabolism. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and practice of medical genetics, Churchill Livingstone, Edinburgh etc., pp. 1267-1285. 1245. Niebuhr E. (1974). Triploidy in man, Hum. Genet., 21, 103-125. 1246. Nienhuis A. W. (1978). Mapping the human genome, N. Engl. J. Med., 299, 195-196. 1247. NorumK.R. (1978). Genetic and nongenetic hyperlipidemia and Western diet, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genetic. [Supl. 1], 125-130. 1248. Ohno S. (1976). A hormone-like action of H-Y antigen and gonadal development of XY/XX mosaic males and hermaphrodites, Hum. Genet, 35, 21-25. 1249. Ohno S. (1976). Major regulatory genes for mammalian development, Cell, 7, 315-321. 1250. Omenn O.S., Motulsky A.G. (1978). "Ecogenetics": genetic variation in susceptibility to environmental agents. In: Cohen B. H., Lilienfeld A. M., Huang P. C. (eds.), Genetic issues in public health and medicine, pp. 83-111, Thomas, Springfield.
1252. OrkinS.H., Alter B. P., Italy C., Mahoney M. J., Lasarus H., Hobbins J. C., Nathan D.G. (1978). Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion, N. Engl. J. Med., 299, 166-172. 1253. OrkinS.H., Kazazian H.H. Jr. (1984). The mutation and polymorphism of the human ß-globin gene and its surrounding area, Ann. Rev. Genet, 18, 131 171. 1254. OrkinS.H., Markham A.F., Kazazian H.H. (1983). Direct detection of the common Mediterranean thalassemia gene with synthetic DNA probes. An alternative approach for prenatal diagnosis, J. Clin. Invest., 71, 775. 1255. Ortigoza-Ferado J., Richter R. J., HornungS.K., Motulsky A. G., Furlong C.E. (1984). Paraoxonase hydrolysis in human serum mediated by a genetically variable arylesterase and albumin, Am. J. Hum. Genet, 36, 295-305. 1256. Osborne W.R.A., ChenS.H., Giblett E.R., Biggar W.D., Ammann A.J., Scott C.R. (1977). Purine nucleoside phosphorylase deficiency: evidense for molecular heterogeneity in two families with enzyme deficient members, J. Clin. Invest., 60, 741-746. 1257. Ottolenghi S., Comi P., Giglioni В., Tolstoshev P., Lanyon W. G., Mitchell G. J., Williamson R., Russo G., Musumeci S., Schiliro G., Tsistrakis G.A., Carache S., Wood W.G., Clegg J.B., Weather all D. J. (1976). δβ thalassemia is due to a gene deletion, Cell, 9, 71. 1258. Otton S. V., Inaba T., Kalow W. (1983). Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs, Life Scienses, 32, 795-800. 1259. Paigen В., Gurtoo H.G., Minowada J. et al. (1977). Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk, N. Engl. J. Med., 297, 346-350. 1260. Pauling L., Itano H.A., Singer S.J., Wells I.C. (1949). Sickle cell anemia: a molecular disease, Science, 110, 543. 1261. Pearl E.R., Vogler L.В., Okos A.J., Crist W.M., Lavaton A. R. HI, Cooper M.D. (1979). B-lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody deficiency states, J. Immunol., 120, 1169-1175. 1262. PenroseL.S. (1935). Inheritance of phenylpyruvic anemia (Phenylketonuria), Lancet, П, 192-194. 1263. PenroseL.S., QuastelJ.H. (1937). Metabolic studies in phenylketonuria, Biochem. J., 31, 266-271. 1264. Percy A. K. (1983). The gangliosidoses and related lipid storage diseases. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and practice of medical genetics, Vol. 2, Churchill Livingstone, Edinburgh etc., pp. 13661388. 1265. Perutz M.F. (1976). Structure and mechanism of haemoglobin, Brit. Med. Bull., 32, 195-208. 1266. Palmar S.H., Stern R.C., Schwartz A. L., Wetzler E.M., Chase P. A., Hirschhorn R. (1976). Enzyme replacement therapy for adenpsine deaminase deficiency and severe combined immunodeficiency, N. Engl. J. Med, 295, 1337-1343. 1267. Palmar S.H., Wetzler E.M., Stern R.C., Martin D. W. Jr. (1978). Evidence for the role of ribonucleotide reductase inhibition in adenosine deaminase deficiency, Pediatr. Res. 1268. Price Evans D.A. (1984). Survey of the human acetylator polymorphism in spontaneous disorders, J. Med. Genet, 21, 243-253. 1269. Prins H»K., OortM., Loos J. A. Zürcher C., Beckers T. (1966). Congenital nonspherocytic hemolytic anemia associated with glutathione deficiency of the erythrocytes, Blood, 27, 145. 1270. Propping P. (1978). Pharmacogenetics Rev. Physiol. Biochem. Pharmacol., 83, 124-173. 1271. Propping P. (1984). Genetic aspects of neurotoxicity. In: Blum K., Manzo L. (eds.), Neurotoxicology, Marcel Dekker Inc., New York, pp. 203-218. 1272. Proudfoot N.J., Brownlee G.G. (1976). Литература 285 Nucleotide sequences of globin messenger RNA, Br. Med. Bull., 32, 251-256. 1273. Proudfoot N.J., Gil A., Maniatis T. (1982). The structure of the human zeta globin gene and a closely linked nearly identical pseudogene, Cell, 31, 553. 1274. Pyke K. W., Dosch H.-M., Ipp M.M., Gelfand E. W. (1975). Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease, N. Engl. J. Med., 295, 424-428.
1276. Raghuram T.C., Koshakji R.P., Wilkinson G. R., Wood A. J. J. (1984). Polymorphic ability to metabolize propanolol alters 4-hydroxy propanolol levels but not beta-blockade, Clin. Pharmacol. Therapy, 36, 51-56. 1277. RatnoffO.D. (1978). Hereditary disorders of hemostasis. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), The metabolic basis of inherited disease, 4th ed., McGraw-Hill, New York, pp. 1755-1791. 1278. RatnoffO.D., Jones P.K. (1977). The laboratory diagnosis of the carrier state for classic hemophilia, Ann. Intern. Med., 86, 521. 1279. Reed T., Young R.S. (1982). Maternal effects in dermatoglyphics: Similarities from twin studies among palmar, plantar and fingertip variables, Am. J. Hum. Genet, 34, 349-352. 1280. Reidenberg M.M., Drayer D.E. (1978). Aromatic amines and hydrazines, drug acetylation, and lupus erythematosus, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genet. [Suppl. 1], 57-64. 1281. Ricco G., MazzaU., Turi R.M., Pich P.G., Camaschella C., Saglio G., Benini L.F. (1976). Significance of a new type of human fetal hemoglobin carrying a replacement isoleucine-threonine at position 74 (El9) of the γ chain, Hum. Genet, 32, 305-313. J282. Romeo G. (1977). Analytical review, Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level, Hum. Genet., 39, 261-276. 1283. Ron H.D., Mulz D. (1983). Duchenne's muscular dystrophy: Carrier detection by muscle ultrasound, J. Genet. Hum., 31, 63-65. 1284. Ruddy S., Austen K. F. (1978). Inherited abnormalities of the complement system, In: The metabolic basis of inherited disease, 4th ed., Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), McGraw-Hill, New York, pp. 1737-1754. 1285. Sahi T. (1978). Intestinal lactase polymorphism and dairy foods, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genet. [Suppl. 1], 115-124. 1286. Sandhoff K. Christomanou H. (1979). Bioche: mistry and genetics of gangliosidoses, Hum.; Genet, 50, 107- 143. Î287. Scott C.R. (1983). Disorders of amino acid \ metabolism. In: Emery A. E. H., Rimoin D. L. [ (eds.), Principles and Practice of Medical Genetics, Churchill Livingstone, Edinburgh etc., pp. 1241-1266. 288. Scott C.I. (1973). The genetics of short stature, Prog. Med. Genet, 8, 243-299. 1289. ScriverC.R. (1969). Treatment of inherited disease: Realized and potential, Med. Clin. North Am., 53, 941-963. 1290. ScriverC.R., Clow C.L. (1980). Phenylketonuria and other phenylalanine hydroxylase mutants in man, Ann. Rev. Genet, 14, 179-202. 1291. ScriverC.R., Mackenzie S., Clow C.L., Delvin E. (1972). Thiamine-responsive maple syrup urine disease, Lancet, 1, 310-312. 1292. Sears D. A. (1978). The morbidity of sickle cell trait. A review of the literature, Am. J. Med., 64, 1021-1036. 1293. Seegmiller J. E. (1980). Disease of purine and pyrimidine metabolism. In: Bondy P. K., Rosenberg L. E. (eds.), Metabolic control and disease, 8th ed., W. B. Saunders Cop., Philadelphia, pp. 777-937. 1294. Seegmiller J.E. (1983). Disorders of purine and pyrimidine metabolism. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and Practice of Medical Genetics, Churchill Livingstone, Edinburgh etc., pp. 1286-1305. 1295. Seegmiller J.E., Rosenbaum P.M., Kelly W.N. (1967). An enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis, Science, 155, 1682. 1296. Seidegaard J., Pero R.W. (1985). The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes, Hum. Genet, 69, 66-68. 1297. Semenza G. (1981). Intestinal oligo- and disaccharides. In: Rändle P.J., Steiner D. F., Whelan W. J. (eds.), Carbohydrate metabolism and its disorders, Vol. 3, Academic Press, London, pp. 425-479. 1298. Serjeant G.R. (1974). The clinical features of sickle cell disease, Clinical Studies. IV. North Holland, Amsterdam. 1299. Sibert J.R., Harper P.S., Thompson R.J. et al. (1979). Carrier detection in Duchenne muscular distrophy. Evidence from a study of oligatory carrier and mothers of isolated cases, Arch. Dis. Child, 54, 534-537. 1300. Simpson J.L. (1983). Disorders of gonads and internal reproductive ducts. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and practice of medical genetics, Churchill Livingstone, Edinburgh, pp. 1227-1240. 1301. Siniscalco M. (1979). Approaches to Human Linkage. Progress in Medical Genetics, NS Vol. 3, Saunders, Philadelphia, pp. 221-307. 1302. Singh R.P., Can D.H. (1967). Anatomic findings in human abortions of known chromosomal constitution, Obstet. Gynecol., 29, 806. 1303. Sinnot E. W., Dunn L. C., Dobzhansky T. (1958). Principles of genetics, 5th ed., McGraw-Hill, New York. 1304. SlightonJ.L., BlechlA.E., Smithies O. (1980). Human fetal G-gamma- and A-gamma-globulin genes: complete nucleotide sequences suggest that DNA can be exchanged in these duplicated genes, Cell, 21, 627-638. Литература 1305. Sloan T. P., Mahgoub Α., Lancaster R., Idle J.R., Smith R. L. (1978). Polymorphism of carbon oxidation of drugs and clinical implications, Br. Med. J., 2, 655-657. 1306. Sly W.S., Achard D. T., Kaplan A. (1977). Correction of enzyme deficient fibroblasts: Evidence for a new type of pinocytosis receptor which mediates uptake of lysosomal enzymes, (Abstract) Clin. Res., 25, 471A. 1307. Smithies O. (1955). Grouped variations in the occurence of new protein components in normal human serum, Nature, 175, 307-308. 1308. Smithies 0. (1955). Zone electrophoresis in starch gels: Group variations in the serum proteins of normal human adults, Biochem. J., 61, 629-641. 1309. Spencer N., Hopkinson D.A., Harris H. (1968). Adenosine deaminase polymorphism in man, Ann. Hum. Genet, 32, 9-14. 1310. Sperling O., Boer P., Eilam G., de Vries A. (1972). Evidence for molecular alteration of erythrocyte hypoxanthine-guanine phosphoribosyl transferase in a gouty family with partial deficiency of the enzyme, Rev. Eur. Etudes Clin. Biol., 17, 72-75. 1311. Spielberg S.P., Gordon G.B., Blake D.A., Goldstein D. A., Herlong H.F. (1981). Predisposition to phenytoin hepatotoxicity assessed in vitro, N. Engl. J. Med., 305, 722-727. 1312. Spranger J. (1972). The systemic mucopolysaccharidoses, Ergeb. Inn. Med. Kinderheilk [NF], 32, 165. 1313. Spranger J. (1983). The mucopolysaccharidoses. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and Practice of Medical Genetics, Churchill Livingstone, Edinburgh, pp. 13391347. 1314. Spritz R. Α., DeRielJ.K., Forget B. G., WeissmanS.M. (1980). Complete nucleotide sequence of the human delta-globin gene, Cell, 21, 639-646. 1315. Suskind S.R., Yanofsky C., Bonner D.M. (1955). Allelic strains of neurpspora lacking tryptophan synthetase: A preliminary immunochemical characterization, Proc. Natl. Acad. Sei USA 41 577 1316. Swift M.,' Chase Ch. (1979). Cancer in farmlies with Xeroderma pigmentosum, J. Natl. Cancer Inst., 62, 1415-1421. 1317. SchmidC., Deininger P.L. (1975). Sequence organization of the human genome, Cell, 6, 345-358. 1318. Schnyder U. W. (1976). Hereditäre Epidermolysen: Klassifikation, Erbprognose und Therapie, Fortschr. Prakt. Dermatol., 8, 1-8. 1319. Schroeder W.A., Huisman T.H.J. (1978). Human gamma chains: structural features. In: Stamatoyannopoulos G., Nienhuis A. (eds.), Cellular and molecular regulation of hemoglobin switching, Grane and Stratton, New York, pp. 29-45. 1320. Stamatoyannopoulos G. (1972). The molecular basis of hemoglobin disease, Ann. Rev. Genet., 6,47. 1321. Stamatoyannopoulos G., Nienhuis A. W. (eds.) (1985). Experimental Approaches for the Study of Hemoglobin Switching, Alan. R. Liss, New York. 1322. Steinheider G., Melderis H., Ostertag W. (1975). Embryonic ε chains of mice and rabbits, Nature, 275, 714-716. 1323. Stokes P. L., Asquith P., Cooke W.T. (1973). Genetics of coeliac disease, Clin. Gastroenterol., 2, 547-556. 1324. Studencki A.B., Conner B.J., ImpraimC.C, Teplitz R.L., Wallace R.B. (1985). Discrimination among the human ßA, ßs and ßc-globin genes using allelespecific oligonucleotide hybridization probes, Am. J. Hum. Genet., 37, 42-51. l324a.Takizawa T., Huang I.-Y., Ikuta T., Yoshida A. (1986). Human glucose-6-phosphate dehydrogenase: primary structure and cDNA cloning, Proc. Natl. Acad. Sei. USA, in press. 1325. Taliaferro W.H., Huck J. G. (1923). The inheritance of sickle cell anaemia in man, Genetics, 8, 594. 1326. Tang B.K., Grant D.M., Kalow W. (1983). Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man, Drug Metab. Dispos., 11, 218-220. 1327. Tarni S., Kono N.. Nasu T., Nishikawa M. (1969). Enzymatic basis for the coexistence of myopathy and hemolytic disease in inherited muscle phosphofructokinase deficiency, Biochem. Biophys. Res, Commun., 34, 77. 1328. Thalhammer О., Havelec L., Knoll E., Wehte E. (1977). Intellectual level (I. Q.) in hétérozygotes for phenylketonuria (PKU), Hum. Genet., 38, 285—288 1328а.Г/геш S.L., Wainscoat J.S., Lynch J.R., Weatherall D.J., Sampietro M., Fiorelli G. (1985). Direct detection of β* 39 thalassaemic mutation with Mae 1, Lancet, 1, 1095. 1329. Tilghman S.M., Tiemeyer D.C., Seirman J.G., Peterlin B. M., Sullivan M., Maizel J. V., Leder P. (1978). Intervening sequence of DNA identified in the structural portion of a mouse ß-globin gene, Proc. Natl. Acad. Sei. USA, 75, 725-729. 1329a.Tonegawa S. (1983). Somatic generation of antibody diversity, Nature, 302, 575-581. 1330. Toniolo D., Persico M.G., Battistuzzi G., Luzzatto L. (1984). Partial purification and characterization of the messenger RNA for human glucose-6-phosphate dehydrogenase, Mol. Biol Med., 2, 89-103. 1331. UdenfriendS., Cooper J.R. (1952). The enzymatic conversion of phenylalanine to tyrosine, J. Biol. Chem., 194, 503. 1332. Utermann G., Langenbeck U., Beisiegel U., Weber W. (1980). Genetics of the apolipoprotein E system in man, Amer. J. Hum. Genet, 31, 339-347. 1333. Valentine W. N., Fink K., PagliaD.E., Harris S. R., Adams W. S. (1974). Hereditary hemolytic anemia with human erythrocyte pyrimidine S' nucleotidase deficiency, J. Clin. Invest, 54, 866-879. Литература 287 034. Valentine W. N., PagliaD.E., Tartaglia A.P., Gilsanz F. (1977). Hereditary hemolytic anemia with increased adenosine triphosphate, Science, 195, 783-784. 1335. Vesell E. S. (1973). Advances in pharmacogenetics. In: Prog. Med. Genet., 9, 291-367. 1336. Vischer T. L. (1983). Pharmacogenetics in therapy with gold and other slow-acting antirheumatic drugs, Rheumatology, 8, 220228. 1337. Vogel F. (1959). Moderne Probleme der Humangenetik, Ergeb. Inn. Med. Kinderheilk, 12, 52-125. 1338. Vogel F. (1964). Eine vorläufige Abschätzung der Anzahl manschlicher Gene, Z. Menschl. Vererbungs-Konstitutionslehre, 37, 291-299. 1339. Vogel F. (1964). Preliminary estimate of the number of human genes, Nature, 201, 847. 1340. Vogel F. (1984). Relevant deviations in hétérozygotes of autosomal-recessive diseases, Clin. Genet., 25, 381-415. 1341. Wachtel S.S. (1977). H-Y antigen and the genetics of sex determination, Science, 198, 797-799. 1342. Wachtel S. (ed.) (1981). Errors of sex determination (Proc. of the Kroc. Foundation Conf), Hum. Genet., 58, 1-127. 1343. Wachtel S. S., Ohno S., Loo G. С., Boyse E. A. (1975). Possible role of H-Y antigen in primary sex determination, Nature, 257, 235-236. 1344. Wainscoat J. S., Thein S. L., Higgs D. R., Bell J. L, Weatherall D. J., Al-Awamy B. H., Serjeant G.R. (1985). A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease, Br. J. Haematol., 60, 261-268. ima.Weinwright B.J. (etal.) (1985). Localization of cystic fibrosis locus of human chromosome 7cen-p22, Nature, 318, 384-385. 1345. Waller H.D., Benöhr A.Chr. (1976). Enzymdefekte in Glykolyse und Nucleotidstoffwechsel roter Blutzellen bei nichtspherocytären hämolytischen Anämien, Klin. Wochenschr., 54, 803-850. 1346. Wang T., Roden D. M., Wolfenden H. T., WoolseyR.L., WoodA.J.J., Wilkinson G.R. (1984). Influence of genetic polymorphism on the metabolism and disposition of encainide in man, J. Pharmacol. Exp. Therap., 228, 605-611. 1347. Watson J.D., Crick F.H.C. (1953). The structure of DNA, Cold Spring Harbor Symp. Quant. Biol, 18, 123-132. 1348. Weatherall D. J. (ed.) (1976). Hemoglobin: Structure, function and synthesis, Br. Med. Bull, 32, (3) 193-287. 1349. Weatherall D.J., Clegg J.B. (1976). Molecular genetics of human hemoglobin, Ann. Rev. Genet, 10, 157-178. 1350. WeatherallD. J., Clegg J.B. (1981). The tha; lassemia syndromes, 3rd ed., Blackwell, ί Oxford. 1351. Weatherall D. J., Wainscoat J. S., Thein S. L., Old J. M., Wood W. G., Higgs D. R., Clegg J. B. (1985). Genetic and molecular analysis of mild forms of homozygous ß-thalassemia, Ann. NY Acad. Sei., 445, 68-80. 1352. Weatherall D.J., WoodW.G., Jones R.W., Clegg J.B. (1985). The developmental genetics of human hemoglobin. In: Experimental Approaches for the Study of Hemoglobin Switching, Stamatoyannopoulos G., Nienhuis A. W. (eds.), Alan R. Liss, New York, pp. 3-25. 1353. WedlundP.J., Aslanian W.S., McAllister C.B., Wilkinson G. R., Branch R. A. (1984). Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism, Clin. Pharmacol. Therap., 36, 773-780. 1354. Weinshilboum R.M., SladekS.L., (1980). Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity, Am. J. Hum. Genet., 32, 651-662. 1355. White J.M. (1974). The unstable hemoglobin disorders, Clin. Haematol., 3, 333-356. 1356. White J.M. (1976). The unstable hemoglobins, Br. Med. Bull., 32, 219-222. 1357. White J.M., Dacie J.V. (1971). The unstable hemoglobins-molecular and clinical features, Prog. Hematol., 7, 69-109. 1357a.Wji<e R. et al (1985). A closely linked genetic marker for cystic fibrosis, Nature, 318, 382-384. 1358. Wieacker P., Davies K., Pearson P., Ropers H. H. (1983). Carrier detection m Duchenne muscular dystrophy by use of cloned DNA sequences, Lancet, 1, 1325-1326. 1359. Wilkins L. (1950). The diagnosis and treatment of endocrine disorders in childhood and adolescence, Thomas, Springfield. 1360. Williamson R. (1976). Direct measurement of the number of globin genes, Br. Med. Bull., 32, 246-250. 1361. Wilson J.M., Young A.B., Kelley W.N. (1983). Hypoxanthine-guanine phosphoribosyltranspherase deficiency, N. Engl. Med., 309, 900-910. 1362. WolfU., Engel W. (1972). Gene activation during early development of mammals, Hum. Genet., 15, 99-118. 1363. Wolfe L.C., John K.M., Falcone J.C., Byrne A.M., Lux S.E. (1982). A genetic defect in the binding of protein 4.1 to spectrin in a kindred with hereditary spherocytosis, N. Engl. J. Med., 307, 1367-1374. 1363a.Woo S.L.C., Guttler F., Ledley F.D., Lidsky A. S., KwokS.C.M., DiMlaA.G., Robson K. J. H. (1985). The human poenylalanine hydroxylase gene. In: (K. Berg, ed.) Medical genetics Past, present, future, New York, A. R. Liss, pp. 123-135. 1364. Wood W.G., Clegg J.B., Weatherall D. J. (1977). Developmental biology of human gemoglobins. In: Progress in hematology, Brown E. B. (ed.), Vol. X, Grune and Stratton, New York, pp. 43-90. 1365. Worthy Т.Е., Grobner W., Kelley W.N. (1974). Hereditary orotic aciduria: Evidence for a Литература structural gene mutation, Proc. Natl. Acad. Sei. USA, 71, 3031-3035. 1366. Yoshida A. (1968). Subunit structure of human glucose-6-phosphate dehydrogenase, Biochem. Genet, 2, 237. 1367. Yoshida A. (1982). Molecular basis of difference in alcohol metabolism between Orientals and Caucasians, Jpn. Hum. Genet, 27, 55-70. 1368. Yoshida A., Beutler E. (1983). G-6-PD variants: another up-date, Ann. Hum. Genet, 47, 2538. 1369. Van ZeelandA.A., Van Diggelen M.C.E., Simons J. W.I. M. (1972). The role of metabolic cooperation in selection of hypoxanthine guanine phosphoribosyl transferase (HGPRT) deficient mutants from diploid mammalian cell strains, Mutation Res., 14, 355-363. 1370. Zenzes M. T., Wolf U., Günther E., Engel W. (1978). Studies of the function of H-Y antigen: dissociation and reorganization experiments on rat gonadal tissue, Cytogenet Cell Genet, 20, 365-372. 1371. Zimmermann U., Riemann F., Pilwat G. (1976). Enzyme loading of electrically homogeneous human red blood cell ghosts by dielectric breakdown, Biochim. Biophys. Acta, 436, 460-474. Литература к главе 5 1372. Abrahamson S., Bender Μ.Α., Conger A.D., WolffS. (1973). Uniformity of radiation induced mutation rates among different species, Nature, 245, 460-462. 1373. Altland K., Kaempfer M., Forssbohm M., Werner W. (1982). Monitoring for changing mutation rates using blood samples submitted for PKU screening. In: Human Genetics, Part A, The unfolding genome, A Liss, New York, pp. 277-287. 1374. AmesB.N., McCannJ., Yamasaki E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test, Mutation Res., 31, 347-364. 1375. Anonymous (1982). Identifying and estimating the genetic impact of chemical environmental mutagens. The National Academy Press, Washington. 1376. Anonymous (1983). International Commission for Protection against environmental mutagens and carcinogens, Committee 4 report, Mutation Res., 115, 255-291. 1377. Anonymous (1982). Ionizing radiation: Sources and biological effects, United Nations Scientific Committee on the Effects of Atomic Radiation, United Nations, New York. 1378. Atwood K. C., Scheinberg S. L. (1958). Somatic variation in human erythrocyte antigens, Sympos. Genet. Approches on Somatic Cell Variation, Gatlinburg, April 2-5, 1958, J. of Cellular and Comparative Physiology, Vol. 52, Suppl. 1, pp. 97-123. 1379. AuerbachC., RobsonJ.M. (1946). Chemical production of mutations, Nature, 157, 302. 1380. Balaban G., Gilbert F., Nichols W, Modems A. T, Shields J. (1982). Abnormalities of chromosome No. 13 in retinoblastomas from individuals with normal constitutional karyotype, Cancer Genet. Cytogenet, 6, 213-221. 1381. BarcinskiM.A., Abreu M.C., de Almeida J. C. C., Naya J. M., Fonseca L. G., Castro L. E. (1975). Cytogenetic investigation in a Brazilian population living in an area of high natural radioactivity, Am. J. Hum. Genet, 27, 802-806. 1382. Barker D., Schafer M., White R. (1984). Restriction sites containing CpG show a higher frequency of polymorphism in human DNA, Cell, 36, 131-138. 1383. Barthelmess A. (1956). Mutagene Arzneimittel, Arzneimittelforsch, 6, 157. 1384. Barthelmess A. (1970). Mutagenic substances in the human environment. In: Vogel F., Röhrborn G. (eds.), Chemical mutagenesis in mammals and man, Springer, Berlin, Heidelberg, New York, pp. 69-147. 1385. Barthelmess A. (1973). Erbgefahren im Zivilisationsmilieu, Goldmann, München. 1386. BartschH.D. (1970). Virus-induced chromosome alterations in mammals and man. In: Vogel F., Rohrborn G. (eds.), Chemical Mutagenesis in Mammals and Man, Springer Verlag, Berlin, Heidelberg, New York, pp. 420432. l386a.Basler A., Buselmaier D., Röhrborn G. (1976). Elimination of spontaneous and chemically induced chromosome aberrations in mice during early embryogenesis, Hum. Genet, 33, 121-130. 1387. Bauchinger M. (1968). Chromosomenaberrationen und ihre zeitliche Veränderungen nach Radium-Röntgentherapie gynäkologischer Tumoren, Strahlentherapie, 135, 553-564. 1388. Behnke H., Holtermann W. (1961). Häufigkeit, Vererbung und klinische Ausprägung der Aniridie in Schleswig-Holstein, Proceedings of the 2nd International Congress, Roma, pp. 1879-1883. 1389. Benedict W.F., Murphree A.L., Banerjee A., Spina C.A., Sparkes M. C., Sparkes R.S. (1983). Patient with 13 chromosome deletion: Evidence that the retinoblastoma gene is a recessive cancer gene, Science, 219, 973-975. 1390. Benzer S. (1957). The elementary units of heredity. In: McElroy W., Glass B. (eds.), The chemical basis of the redity, pp. 70-93, Johns Hopkins University press, Baltimore. 1391. Berendes U. (1974). Multiple tumors of the skin: Clinical, histopathological, and genetic features, Hum. Genet, 22, 181-210. 1392. Berg K. (ed.) (1979). Genetic damage in man caused by environmental agents, Academic Press, New York, etc. 1393. Bizzozero O.J., Johnson K. G., Ciocco A. (1966). Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964, New Engl. J. Med., 274, 1095. 1394. Blank C. (1960). Apert's syndrome (A type of Литература 289 acrocephalosyndactyly), Observations on a British series of 39 cases, Ann. Hum. Genet, 24, 151-164. 1395. Bloom A. B. (1972). Induced chromosome aberrations in man, Adv. Hum. Genet., 3, 99-172. 1396. Bochkov N.P., Lopukhm Y.M., Kulsehov N.P., Kovalchuk L.V. (1974). Cytogenetic study of patients with ataxia-teleangiectasia, Hum. Genet., 24, 115-128. 1397. Bora K. G., Douglas G. R., Nestmann E. R. (eds.), (1982). Chemical mutagenesis, human population monitoring and genetic risk assessment, Progr. in Mut. Res., Vol. 3, Elsevier, Amsterdam. 1398. Borberg A. (1951). Clinical and genetic Investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis, Munksgaard, Copenhagen. Дата добавления: 2015-12-16 | Просмотры: 394 | Нарушение авторских прав |